These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 10888134)

  • 1. Do cytokeratin-positive-only sentinel lymph nodes warrant complete axillary lymph node dissection in patients with invasive breast cancer?
    Teng S; Dupont E; McCann C; Wang J; Bolano M; Durand K; Peltz E; Bass SS; Cantor A; Ku NN; Cox CE
    Am Surg; 2000 Jun; 66(6):574-8. PubMed ID: 10888134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
    Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
    Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic analysis of sentinel lymph nodes in breast carcinoma.
    Hsieh PP; Ho WL; Yeh DC; Liu TJ; Wu CC; Lin JH; Wang SJ
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Oct; 63(10):744-50. PubMed ID: 11076431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin-positive cells in sentinel lymph nodes in breast cancer are not random events: experience in patients undergoing prophylactic mastectomy.
    King TA; Ganaraj A; Fey JV; Tan LK; Hudis C; Norton L; Cody HS; Borgen PI
    Cancer; 2004 Sep; 101(5):926-33. PubMed ID: 15329899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin staining for intraoperative evaluation of sentinel lymph nodes in patients with invasive lobular carcinoma.
    Weinberg ES; Dickson D; White L; Ahmad N; Patel J; Hakam A; Nicosia S; Dupont E; Furman B; Centeno B; Cox C
    Am J Surg; 2004 Oct; 188(4):419-22. PubMed ID: 15474439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry in breast cancer.
    Choi YJ; Yun HR; Yoo KE; Kim JH; Nam SJ; Choi YL; Ko YH; Kim BT; Yang JH
    Jpn J Clin Oncol; 2006 Aug; 36(8):489-93. PubMed ID: 16790449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer.
    Mullenix PS; Brown TA; Meyers MO; Giles LR; Sigurdson ER; Boraas MC; Hoffman JP; Eisenberg BL; Torosian MH
    Am J Surg; 2005 May; 189(5):606-9; discussion 609. PubMed ID: 15862505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
    Chagpar A; Middleton LP; Sahin AA; Meric-Bernstam F; Kuerer HM; Feig BW; Ross MI; Ames FC; Singletary SE; Buchholz TA; Valero V; Hunt KK
    Cancer; 2005 Apr; 103(8):1581-6. PubMed ID: 15747375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Nogi H; Suzuki M; Kamio M; Kato K; Kawase K; Toriumi Y; Takeyama H; Fukushima H; Morikawa T; Uchida K
    Oncol Rep; 2011 Apr; 25(4):1109-15. PubMed ID: 21308353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in breast cancer.
    Gray RJ; Pockaj BA; Conley CR
    Ann Surg Oncol; 2004 Dec; 11(12):1056-60. PubMed ID: 15545503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
    Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY
    Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry. Part II. Results.
    Salem AA; Douglas-Jones AG; Sweetland HM; Mansel RE
    Eur J Surg Oncol; 2006 Jun; 32(5):484-7. PubMed ID: 16569493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The reliability and accuracy of intraoperative imprint cytology of sentinel lymph nodes in breast cancer.
    Pogacnik A; Klopcic U; Grazio-Frković S; Zgajnar J; Hocevar M; Vidergar-Kralj B
    Cytopathology; 2005 Apr; 16(2):71-6. PubMed ID: 15787648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of axillary sentinel lymph node detection in the staging of early lobular invasive breast carcinoma: a prospective study.
    Classe JM; Loussouarn D; Campion L; Fiche M; Curtet C; Dravet F; Pioud R; Rousseau C; Resche I; Sagan C
    Cancer; 2004 Mar; 100(5):935-41. PubMed ID: 14983488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of immunohistochemistry positivity in sentinel nodes which are negative on haematoxylin and eosin in breast cancer.
    Giobuin SM; Kavanagh DO; Myers E; Doherty AO; Quinn CM; Crotty T; Evoy D; McDermott E
    Eur J Surg Oncol; 2009 Dec; 35(12):1257-60. PubMed ID: 19497702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.